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1.  INTRODUCTION
Composites comprising calcium phosphates and natural
biopolymers are widely used as biomaterials for bone
tissue repair and engineering [1–5]. Hydroxyapatite,
Ca10(PO4)6(OH)2, has been used as a principal inorganic
component of synthetic materials for orthopaedy and
stomatology for a long time. This mineral can be regarded,
with some limitations, as a crystallochemical analogue of
the main mineral constituent of human and animal
skeletal tissues [6]. A wide range of biomaterials for
different clinical applications can be created on the basis
of two components: nanocrystalline apatite and chitosan
[3–5, 7–22]. Chitin is the second (after cellulose) most
abundant natural polysaccharide. It forms the skeletal
system of arthropoda; it is also present in the cell walls of
fungi and bacteria. The hardness of the chitin skeletal
structures of arthropoda is caused by the formation of
natural chitin-calcium carbonate-protein complexes.
Chitosan is a derivative of chitin, obtainable by chitin
deacetylation. Chitin and chitosan are polymorphous non-
crystalline or partly crystalline biopolymers. Both of them
contain the same monomers, N-acetyl-2-amino-2-deoxy-
D-glucopyranose and 2-amino-2-deoxy-D-glucopyranose,
differing in the relative content of acetylated and
deacetylated monomers. Chitin and chitosan are
promising materials for medical applications due to their
bacteriostatic/bactericidal properties, biocompatibility
with human tissues, and the ability to facilitate
regenerative processes in healing wounds [17]. In recent
years interest in chitosan–hydroxyapatite composite
biomaterials has increased significantly, evidenced by the
significant growth in the number of scientific articles
reporting their characterization and testing.
Several schemes of such composite material
production have been developed. Most of them involve
two major stages: first, synthesis of the organic polymeric
scaffolds of pure or chemically treated and modified
chitosan; and second, mineralization of the scaffold in the
simulated body fluid (the biomimetic way) or in saturated
matrix solutions [7–20]. The scaffolds can be made in the
form of membranes, microspheres [27] or multilayered
materials. The chitosan can be combined with other macro-
molecules, such as silk fibroin or carboxymethylcellulose
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[11, 14]; chitin can also be used as a scaffold [13, 22]. An
inverse approach has also been described, viz., preforma-
tion of a porous hydroxyapatite scaffold followed by its
impregnation with chitosan [8].
The composites obtained in such ways were
characterized by different physicochemical methods to
test their potential as biomaterials, and also the series of
biocompatibility tests using cell cultures were performed,
confirming biocompatibility of these composites [8–14].
Yamaguchi et al. [3] have described a one-step scheme
of chitosan–hydroxyapatite synthesis, in which the
composite was coprecipitated by dropping chitosan
solution containing phosphoric acid into a calcium
hydroxide suspension. Rusu et al. have developed a
stepwise coprecipitation approach [4], using it to obtain
different types of chitosan–hydroxyapatite composites
with different ratios between the components. These
composite materials have been thoroughly characterized
by physicochemical techniques and have been found to
contain nanosized hydroxyapatite with structural features
close to those of biological apatites. A further development
of this approach was pursued by Chesnutt et al., who
developed microsphere-based chitosan–nanocrystalline
calcium phosphate composite scaffolds [26].
A combination of physicochemical and structural
characterization of the biomaterials with the results of
preclinical in vivo investigations is necessary to find out
how changes in the structure and composition of the
materials affect their behaviour in living organisms. Since
the chitosan–hydroxyapatite materials could be used in
bone regeneration as scaffolds in the applications of
auto- or allografts, which would otherwise be impossible
for some reason or another, the investigation of the
processes of biodegradation in vivo is important for
further progress in this area, as long as an ideal scaffold
material is not yet available. In the present work we tried
to synthesize, characterize and evaluate the in vivo
behaviour of the simplest (uniform, made by a one-step
technique) chitosan–hydroxyapatite materials. It is the
first step towards the in vivo investigation of more
complicated scaffold systems.
2 MATERIALS AND METHODS
2.1 Materials preparation and characterization
The examined series of materials had different chitosan–
apatite concentration ratios. Substances were obtained
by adding aqueous solutions of CaCl2 and NaH2PO4
(keeping the Ca/P ratio equal to 1.67) to a 0.2% solution
of 75–85% deacetylated low molecular weight chitosan
(Sigma-Aldrich, Brookfield viscosity = 20 200 cP, 1% in
1% acetic acid) in 1% acetic acid. The requisite pH level
was maintained by adding NaOH. The detailed sample
preparation varied according to each specimen of a
series, as listed in Table 1. The products of the synthesis
were aged for 24 h at room temperature, rinsed
thoroughly, and then dried. Water content and chitosan-
to-apatite ratio were estimated by weighing the sample
before and after annealing in air at 130 °C and 900 °C for
45 minutes (we assume that the weight loss at 130 °C
corresponds to the water fraction and the weight loss at
900 °C to the polysaccharide fraction [3]).
To obtain the porous materials, wet (i.e., not dried
completely) substances were lyophilized using a
laboratory-built glass vacuum system with liquid nitrogen.
Infrared spectra were measured on a Perkin-Elmer
Spectrum One spectrometer. Before examination, the
powdered samples were mixed with KBr powder (2.5–
3.0 mg of chitosan–apatite composite and 300 mg of KBr)
and pressed into a solid disk.
The Vickers hardness of the solid samples was
measured by the conventional method.
The X-ray diffraction (XRD) crystallographic
investigations were performed using DRON4-07 dif-
fractometer (“Burevestnik”, Russia). The Ni-filtered Cu Kα
radiation (wavelength 0.154 nm) was used with a
conventional ϑ-2ϑ Bragg-Brentano geometry (2ϑ is the
Bragg angle). The current and voltage of the X-ray tube
were 20 mA and 30 kV respectively. The samples were
measured in the continuous registration mode (at a speed
of 2 °/min) within the 2ϑ-angle range from 8 to 60°. All
experimental data processing procedures were performed
with the program package DIFWIN-1 (“Etalon PTC” Ltd).
Scanning electron microscopy with X-ray microanalysis
was performed using a REMMA102 electron microscope
(SELMI, Ukraine). This instrument allows visualization of
the sample surface over a wide range of magnifications
with a limiting resolution of ca 10 nm. The characteristic
X-ray emission excited by the electron probe (accelerating
voltage 20 kV, probe current 2 nA) collected by an energy
dispersive X-ray (EDX) detector was used to determine
the elemental composition of the sample by scanning over
a 50 × 50 μm2 area of the surface. To avoid surface charge
accumulation the samples were coated with a thin
(30–50 nm) layer of silver in a VUP-5M vacuum device
(SELMI, Ukraine).
2.2 Animal tests
For the in vivo tests, 48 laboratory rats 4 months old were
used, duly observing the requirements of the Ukrainian
National Act of Animal Protection against Cruel
Treatment (Act #3447-IV 21.02.2006) regulating the
care and use of laboratory animals. Perforated defects,
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diameter 2 mm were made in a sterile operating room
with a stomatological borer in the middle third of the right
tibia of the animals. The 50/50 chitosan–hydroxyapatite
scaffolds were chosen for in vivo evaluation. In the
experimental group of animals the cylindrical ChAp rods
were implanted into the traumata; the diameter of the
rods being equal to the width of the wound channel. The
control group consisted of rats with analogous tibial
defects not filled with the investigated material. The
animals were taken out of the experiment 5, 10, 15 and
24 days after implantation. The phases of removal
corresponded to the main stages of reparative
osteogenesis [23]. The extracted bones with the defects
were fixed in 10% formalin and then embedded in
paraffin in order to prepare histological specimens. Some
bones were treated with glutaraldehyde for electron
microscopy. The histological and histomorphological
analyses of the extracted tissues were performed at the
phases of reparative bone regeneration.
2.3 Characterization of specimens after the in vivo tests
The elemental composition and morphological
characteristics of the tissues were obtained by scanning
electron microscopy together with X-ray microanalysis.
At the same time, the blood samples were taken from the
caudal vein for biochemical analysis. The crude protein in
blood plasma was estimated by the Lowry method. The
calcium content in blood plasma was examined using a
murexide–glycerin reagent. Alkaline phosphatase activity
was determined via the decomposition of phenylphosphate
with the formation of phenol and consequent reaction of
phenol with 4-aminophenazone.
To prepare histological specimens, the defect sites
were extracted, fixed in a 10% solution of neutral
formalin, decalcified in EDTA solution over two months,
dehydrated in aqueous alcohol solutions with increasing
alcohol concentrations, and finally embedded in paraffin.
Histological microscopic sections 10–12 μm thick were
prepared and stained with azure–eosine and by van
Giezon’s reagent [24]. The microscopic sections were
then examined using an Olympus light microscope
equipped with a digital camera.
A morphometry study was carried out using the
specialized computer programs “VideoTest 5.0” and
“VideoSize 5.0” (St. Petersburg, Russia). Five days after
the defects were made, the cellular composition of the
regenerated tissue was investigated, i.e. the percentage
populations of certain cells with respect to the total
amount of cells in the site of the defect. The numbers of
fibroblasts, macrophages, lymphocytes, plasmocytes,
neutrophils, and undifferentiated cells were determined.
In the histologic specimens of the next stages of reparative
osteogenesis the percentage of granulation tissue,
fibroreticular tissue, membrane reticulated and splenial
bone tissues, as well as the percentage of the red bone
marrow, were determined. The width of bone trabeculae at
the periphery and in the central region, and the total area of
vessels in the regenerated tissue, were measured.
3.  RESULTS AND DISCUSSION
The preparation conditions for the series of ChAp
composites and the chitosan-to-apatite ratios estimated
by simple thermogravimetric analysis are given in Table 1.
The water content was estimated from the weight loss
after heating the samples to 130 ºC. The total mineral
(calcium phosphate) content was measured as the
sample weight after complete burnout of the organic
moiety at 900 ºC. The results from the analyses are in
reasonable agreement with the nominal chitosan-to-
apatite ratios.
Ch–Ap preparation Thermogravimetric analysis results 
chitosan 
solution 
mineral solution wt% of components as determined from 
weight loss 
Sample 
No Ch/Ap 
weight 
ratio c 
(wt%) 
V/mL 1 M 
CaCl2 
V/mL 
1 M 
NaH2PO4 
V/mL 
H2O chitosan apatite 
1 ChAp 15/85 
0.2 1000 113.3 68.0 9.0 ± 1.2 14.9 ± 3.09 76.1 ± 3.09 
2 ChAp 30/70 
0.2 1000 46.6 28.0 11.4 ± 0.2 25.4 ± 0.60 63.2 ± 0.60 
3 ChAp 50/50 
0.2 1000 20.0 12.0 3.3 ± 1.0 49.3 ± 2.2 47.4 ± 2.2 
4 ChAp 80/20 
0.2 1000 5.0 3.0 8.9 ± 1.0 73.0 ± 2.0 18.1 ± 2.1 
 
Table 1. Sample preparation conditions and chitosan-to-apatite ratios estimated from thermogravimetric measurements.
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From the IR spectroscopy of the different ChAp
composites we can infer that all the major absorbance
bands of the spectra correspond to hydroxyapatite; their
width increases significantly with increasing chitosan
content (Fig. 1). The bands at 1000–1100 cm–1 and 500–
600 cm–1 correspond to different modes of the PO4 group
in hydroxyapatite. Broadening of the band at 1050 cm–1
shows the presence of polymer and its interaction with
the phosphate groups [20]. The bands at 1420–1485 cm–1
and at about 875 cm–1 are due to the carbonate ions in
apatite. The bands at 1550–1700 cm–1 are attributable to
mode superposition of the hydroxyapatite OH group and
the chitosan amide I and amide II groups. The bands at
3600–3700 cm–1 and 2800–2950 cm–1 are assigned to
the hydroxyl groups present in chitosan [14]. The
hydroxyapatite phosphate stretching (vibration) bands
are at 1000–1100 cm–1 and the phosphate bending bands
are at 500–600 cm–1. The strongest characteristic CO3
bands are also visible, at 1420–1485 cm–1 .
The Vickers hardness of samples with different
chitosan-to-apatite ratios amounted to 0.22 GPa for
ChAp 15/85; 0.15 GPa for ChAp 30/70; 0.12 GPa for
ChAp 50/50; and 0.14 GPa for ChAp 80/20.
The Ca/P ratio determined by EDX microanalysis in
the scanning electron microscope was close to that of
apatite (1.67). There were no pronounced peaks of Na
and Cl (Fig. 3), suggesting that the synthesized apatite did
not have significant substitutions in the cation (Na → Ca)
and anion (Cl → OH) sublattices. A network of micrometre
and submicrometre pores was observed in the lyophilized
materials. Two systems of pores can be visually distinguished
in the micrographs (Fig. 4). The statistical image analysis
using the “VideoTest 5.0” and “VideoSize 5.0” programs
yielded an average diameter of 30 μm for “small” pores
and 50 μm for “big” ones. Such pores could promote bone
tissue growth into the implanted material.
The Ca and P contents from the EDX microanalysis
of the bones of the model animals after the implantation
of solid (nonporous) 50/50 ChAp is shown in Fig. 5. It is
clearly seen that the Ca and P concentrations in the bone
tissue near the defect were restored much faster in the
presence of the implanted ChAp than in the control group.
It should also be noted that Ca content does not track P
content for the implant group. This effect may be due to
the better mobility and mobilization of Ca compared with P,
but the mechanism has not yet been established with certainty.
The implantation of ChAp also reduces calcium
mobilization, since the calcium content in blood plasma of
the rats with implants was normal, in contrast to the
control group of animals. Such reduction of Ca mobilization
can prevent the loss of bone strength that usually
accompanies the regenerative processes. The total protein
content and the alkaline phosphatase activity determined
in the blood of the implanted animals did not differ from
those of the control group.
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Figure 1. IR spectra of hydroxyapatite and chitosan–hydroxyapatite
scaffolds with different chitosan/hydroxyapatite ratios.
XRD patterns suggest the presence of nanocrystal-
line apatite, its crystallinity decreasing with increasing
chitosan content (Fig. 2). Diffraction peak broadening is
inversely proportional to crystallite size, hence the
greater the proportion of chitosan in the composite the
smaller the average size of the apatite crystals.
Qualitative estimation of the profile width of the main
diffraction peaks suggests that for a chitosan/apatite
ratio of 50/50, the size of crystallites in the composite is
comparable with the crystallite size of bioapatite in bone
tissue (~ 20 nm) [25]. Slightly increased intensity of the
(002) and (004) peaks compared with the reference data
suggests that the apatite crystallites are elongated along
the crystallographic axis A (which is also characteristic of
bone tissue bioapatite).
Figure 2. XRD patterns of ChAp samples with different
component ratios.
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)
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Figure 4. Representative scanning electron micrographs showing the microstructure of the porous ChAp.
Figure 3. EDX spectrum of the ChAp 50/50 composite. The Ag signal is from the thin conducting Ag film deposited on the samples.
Figure 5. Calcium and phosphorus contents in the bone tissue near the site of implantation (squares) and at the distance of 15 mm
(circles) vs implantation time. Filled symbols: defect with implant; empty symbols: defect without implant (control).
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These data suggest that the nanosized apatite
crystals incorporated into the chitosan matrix, being
implanted in vivo, participate immediately in the
reparative biochemical processes of the living bone
tissue. We propose that Ca and P from the apatite
crystals of the implanted material are used for
regenerated bone formation. This reduces the need to
mobilize these elements from the bone tissue both in the
areas near the defect and those at a distance.
The porous materials have shown osteoconductive
properties in the in vivo tests. 5 days after implantation,
the pores of ChAp were filled with cells of leukocyte-
macrophage and fibroblastic differons, providing
evidence of progress in the osteoreparative process.
Further, the formation of fibroreticular and membrane
reticulated primary bone tissue trabeculae occurred with
their subsequent calcification and remodelling into the
lamellar bone tissue. Starting from the 10th day, the
integration of ChAp into the newly formed tissue was
observed, and by the 24th day the replacement of the
implant by the young bone had taken place. This
dynamics is specific only for the porous samples of
ChAp. The solid (nonporous) implants did not improve the
histological pattern of the reparative process.
The osteoconductive properties of the ChAp
composite material can be observed after implantation
into the bone defect at the first stages of regenerated
bone tissue development. In Fig. 6, pores filled with cell
and tissue species typical for regeneration are clearly
visible . The young granulation tissue (GT) dominates in
the regenerate, its content is 24 ± 6%. We did not,
however, observe a close connexion of tissue components
with the material of the implant, which can be explained
by the early stage of observations and the high rate of
granulation tissue formation. GT occupies the peripheral
segments of the defect, which was similar to the patterns
observed in the control animals. The central pores of the
implant are filled mostly with the cells of posttraumatic
haematoma, among which there are macrophages,
lymphocytes, fibroblasts, plasmocytes, and undif-
ferentiated cells. The cell percentage corresponded to
that of the control group. In one field of view different
cell phenotypes were observed: young secreting cells,
mature macrophages filled with detritus, and dying cells.
In the inner pores the edges of the materials were
blurred, which could be indicative of the beginning of
ChAp osteointegration and a high activity of cells in this
site of the defect. Both in the peripheral and in the central
pores vascular invasion was observed, mostly of the
sinusoidal type. The vessels were surrounded by a layer
of perivascular cells and secreting fibroblasts, the number
of which was greater in the peripheral sections.
Ten days after the introduction of the implant its rapid
biodegradation takes place with the formation of tissue-
specific structures of the regenerate. From Fig. 7, the
intense growth of fibroreticular tissue (FT) with a more
ordered fibre arrangement can be observed in the zone of
the defect, and also the beginning of formation of the
bone trabeculae formed with the membrane reticulated
bone. FT is situated mostly along the periphery of the
defect, while its central areas are filled with the remains
of granulation tissue with the greatest numbers of
fibroblasts, macrophages and sinusoidal capillaries. For
the first time the formation of membrane reticulated bone
tissue is observed, which can be taken as evidence for
the osteoblastic type of reparative processes. The
percentage of bone tissue corresponds to that in the
control animals (35 ± 10%), so we cannot comment on the
osteoinductive properties of the implant. At the same
time, there is integration of the material in the regenerate
structure and close binding of the forming bone
trabeculae and ChAp.
The histological pattern of the regenerate on the 15th
day is similar to that on the 10th day (Fig. 8). Fibroreticular
and bone tissues were present, the bone tissue had formed
a denser network of trabeculae than in the previous epoch
of observation. Granulation tissue was completely absent.
The active remodelling of membrane reticulated bone into
splenial bone and its mineralization takes place, indicated by
the increase of staining intensity of the bone trabeculae.
The percentages of FT, membrane reticulated bone and
splenial bone were, respectively, 28 ± 8%, 40 ± 10% and
11 ± 3%, the same as in the control series. The remains of
the implant are situated mainly in the centre of the defect,
closely connected with the bone-forming trabeculae and
stained nonuniformly, which suggests their integration into
the newly formed bone matrix.
Figure 6. Area of the tibial defect 5 days after traumatization.
Key: 1, ChAp; 2, pore with posttraumatic haematoma cells;
3, granulation tissue; 4, capillary.
Chitosan–hydroxyapatite composite biomaterials made by a one step co-precipitation method    S.N. Danilchenko et al.    125______________________________________________________________________________________________________
JBPC  Vol. 9 (2009)
mostly by splenial bone in which intensive remodelling is
observable, as indicated by the presence of both
secondary and primary osteons. The number of primary
osteons in this observation stage is much greater. So we
can well assert that completion of the primary formation
of the neogenic bone and the beginning of the remodelling
processes has occurred. The implant remains are closely
integrated into the newly formed matrix and are subject to
biodegradation in the course of bone remodelling.
Figure 7. Area of the tibial defect 10 days after traumatization.
Key: 1, ChAp; 2, granulation tissue; 3, fibroreticular tissue;
4, bone trabeculae.
Figure 8. Area of the tibial defect 15 days after traumatization.
Key: 1, ChAp; 2, fibroreticular tissue; 3, bone trabeculae;
4, “parent” bone.
Figure 9. Area of the tibial defect 24 days after traumatization.
Key: 1, ChAp; 2, fibroreticular tissue; 3, membrane reticulated
bone tissue; 4, splenial bone tissue; 5, osteon; 6, “parent” bone.
On the 24th day of observation, bone tissue occupies
the major area of the defect (Fig. 9). The deeper parts of
the regenerate are formed with membrane reticulated
bone tissue whose stainability is close to that of the
“parent” bone. The number of osteoblasts on the surface
of trabeculae decreases, which indicates that the intense
bone matrix formation process has stopped and the
remodelling processes have begun. The remains of
nondegraded ChAp are pushed off to the periphery and
are on the boundaries with the “parent” bone. Tight
bonding of the implant with the newly formed bone matrix
is observed; less tight bonding with the “parent” bone.
The cortical plate in the site of the defect is formed
4.  CONCLUSIONS
The investigated chitosan–hydroxyapatite composite
materials have proved to be promising for the treatment
of bone defects. The results of the present experiments
suggest the high potential of simple chitosan–hydroxyapatite
composite scaffolds produced by a one-step coprecipitation
method as a filling material for orthopaedy and stomatology.
The porous chitosan–hydroxyapatite materials have shown
good osteoconductive properties in in vivo experiments.
Histomorpologiocal studies have shown that the porous
materials undergo almost complete biodegradation. The
complete replacement of the porous chitosan–hydroxyapatite
composite implant by the newly formed bone tissue
within the bone defect in rats takes place by the 24th day
of implantation.
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